First-Quarter Figures: Sartorius AG on Course for Further Growth
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Sartorius, a leading international laboratory and pharmaceutical equipment provider, got off to a strong start in fiscal 2013 with-currency-adjusted gains of 10.1% in order intake and of 4.2% in sales revenue, as well as an 8.5% increase in profit1). At the same time, development of order intake for the individual divisions was quite uneven. Based on its first-quarter results, Sartorius confirmed its full-year guidance, projecting, under the assumption that the economic environment remains stable, that sales revenue will grow 6.0% to 9.0% in constant currencies and operating profit margin (underlying EBITDA margin) will rise from 19.0% to approximately 19.5% without any currency effects considered.
Help employers find you! Check out all the jobs and post your resume.
Sartorius, a leading international laboratory and pharmaceutical equipment provider, got off to a strong start in fiscal 2013 with-currency-adjusted gains of 10.1% in order intake and of 4.2% in sales revenue, as well as an 8.5% increase in profit1). At the same time, development of order intake for the individual divisions was quite uneven. Based on its first-quarter results, Sartorius confirmed its full-year guidance, projecting, under the assumption that the economic environment remains stable, that sales revenue will grow 6.0% to 9.0% in constant currencies and operating profit margin (underlying EBITDA margin) will rise from 19.0% to approximately 19.5% without any currency effects considered.
Help employers find you! Check out all the jobs and post your resume.